Covered recipient · General Payments record
KACEE BODIFORD
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$2,415.14
- Reported across 125 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $502.27 | 28 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $282.82 | 18 |
| Gilead Sciences, Inc. | $80.70 | 1 |
| Lilly USA, LLC | $29.61 | 2 |
| Acerta Pharma LLC | $28.52 | 2 |
| Novo Nordisk AS | $27.52 | 2 |
| ViiV Healthcare Company | $23.31 | 1 |
| Hologic Sales and Service, LLC | $16.40 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $13.39 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (28)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $11.96 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106784217 | CMS |
| ABBVIE INC. | $7.20 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106784221 | CMS |
| ABBVIE INC. | $2.75 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106784225 | CMS |
| ABBVIE INC. | $3.55 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106784228 | CMS |
| ABBVIE INC. | $11.08 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106784232 | CMS |
| ABBVIE INC. | $125.00 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106784237 | CMS |
| ABBVIE INC. | $24.82 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106784240 | CMS |
| ABBVIE INC. | $30.42 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106784244 | CMS |
| ABBVIE INC. | $4.29 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106784249 | CMS |
| ABBVIE INC. | $8.84 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106784252 | CMS |
| ABBVIE INC. | $15.19 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106784256 | CMS |
| ABBVIE INC. | $8.50 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106784260 | CMS |
| ABBVIE INC. | $6.41 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106784264 | CMS |
| ABBVIE INC. | $12.95 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106784268 | CMS |
| ABBVIE INC. | $2.07 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106784272 | CMS |
| ABBVIE INC. | $2.04 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106784276 | CMS |
| ABBVIE INC. | $2.31 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106784280 | CMS |
| ABBVIE INC. | $3.44 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106784284 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.56 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105893754 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.96 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105758663 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $13.39 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118159961 | CMS |
| Gilead Sciences, Inc. | $80.70 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133690336 | CMS |
| Hologic Sales and Service, LLC | $16.40 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1084908980 | CMS |
| Lilly USA, LLC | $15.18 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135647885 | CMS |
| Lilly USA, LLC | $14.43 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135730284 | CMS |
| Novo Nordisk Inc | $14.20 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100566826 | CMS |
| Novo Nordisk Inc | $13.32 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100517353 | CMS |
| ViiV Healthcare Company | $23.31 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1112828305 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.